Ballast Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Ballast Advisors's PFE Position: Q2 2026 in Review
Ballast Advisors sold out of Pfizer (PFE) in Q2 2026, closing a stake of 3,683 shares — an estimated $103K sold.
Ballast Advisors first reported a position in PFE in Q4 2019 and held it in 19 quarters. The position peaked at $638K in Q4 2021. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Ballast Advisors reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
- Ballast Advisors sold 3,683 Pfizer shares in Q2 2026, an estimated $103K.
- Ballast Advisors first reported a position in Pfizer in Q4 2019 and held it in 19 quarters.
- Ballast Advisors's Pfizer position peaked at $638K in Q4 2021.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Ballast Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.